Tessa Therapeutics is a biotechnology company specializing in the research, clinical development, and commercialization of cancer immunotherapy treatments. The Company is engaged in employing Virus-Specific T cells to treat cancer, and conducting US FDA-registered Phase III T cell therapy trial in NPC, or any cancer indication.
|Employees (est.) (Sept 2021)||182||(-1%)|
Tessa Therapeutics total Funding
Tessa Therapeutics latest funding size
Time since last funding
|4 years ago|
Tessa Therapeutics investors
|Temasek Holdings, EDBI, Karst Peak Capital, Heliconia Capital Management|
Tessa Therapeutics has 643 Twitter Followers. The number of followers has increased 0.2% month over month and increased 0.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Tessa Therapeutics founded?
Tessa Therapeutics was founded in 2011.
Who are Tessa Therapeutics key executives?
Tessa Therapeutics's key executives are Teo Ming Kian, Göran Ando and Jeffrey H. Buchalter.
How many employees does Tessa Therapeutics have?
Tessa Therapeutics has 182 employees.
Who are Tessa Therapeutics competitors?
Competitors of Tessa Therapeutics include Gradalis, Immatics and Cryo-Cell.
Where is Tessa Therapeutics headquarters?
Tessa Therapeutics headquarters is located at 8 Temasek Boulevard, #24-02 Suntec Tower 3, Singapore.
Where are Tessa Therapeutics offices?
Tessa Therapeutics has an office in Singapore.
How many offices does Tessa Therapeutics have?
Tessa Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies